Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: nose-to-brain transport

June 11, 2026 Drug delivery / Pharma applications

Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer’s disease

The co-delivery of rivastigmine hydrogen tartrate (RHT) and asiaticoside (AS) offers a promising strategy for enhancing acetylcholinesterase (AChE) inhibition in

Continue reading

October 12, 2021 CD as API / Drug delivery / Pharma applications

Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?

The use of CDs in nasal formulations allowed obtaining versatile drug delivery systems intended for local and systemic effects, as

Continue reading

Recent Posts

  • HUPHAR 2027
  • Cyclodextrins Target Inflammatory Foam Cells in Multiple Sclerosis Lesions
  • FDA Approves LEMBAZ for Infantile-Onset Niemann-Pick Disease
  • HPBCD beads for drug delivery
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (364)
  • CD derivatives (447)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (835)
  • E-ducation (64)
  • Environmental (144)
  • Events (244)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (429)
  • Other industrial use (115)
  • Pharma applications (1,247)
  • Supramolecular systems (45)
  • Uncategorized (178)

Top Posts

  • Cyclodextrins Target Inflammatory Foam Cells in Multiple Sclerosis Lesions
  • FDA Approves LEMBAZ for Infantile-Onset Niemann-Pick Disease
  • HUPHAR 2027
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease
  • HPBCD beads for drug delivery
  • Special Issue of the journal Materials "Cyclodextrin-Based Nanomaterials: Synthesis, Properties, and Applications”
  • Low sulfur biodiesel produced from sewage enabled by beta-cyclodextrin
  • Chlorine dioxide in α-cyclodextrin as food preservative
  • Honoring Professor Tsuneji Nagai
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,472 other subscribers
Loading Comments...